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The yeast a-factor receptor (Ste3p) is subject to two
mechanistically distinct modes of endocytosis: a
constitutive, ligand-independent pathway links to
vacuolar degradation of the receptor, while a ligand-
dependent uptake pathway links primarily to recycling
and thus, receptor reutilization. Ste3p ubiquitination
triggers its uptake into the constitutive pathway. The
present work considers the role of the receptor ubiquit-
ination associated with the Ste3p ligand-dependent
endocytosis mechanism. The doa4D mutation which
reduces the cellular availability of ubiquitin blocks the
Ste3p constitutive uptake. Uptake into the Ste3p
ligand-dependent recycling pathway, however, con-
tinues unimpaired. The ubiquitin independence of
Ste3p ligand-dependent uptake was further indicated
by analysis of receptor mutants having Lys-to-Arg sub-
stitutions at all possible ubiquitin acceptor sites.
Again, the ligand-induced internalization was unim-
paired. Furthermore, no discernible effect was seen on
either recycling or on the slow PEP4-dependent turn-
over of the receptor (for receptor internalized via the
ligand-dependent mechanism, trafficking to the vacu-
ole/lysosome is the minor, alternate fate to recycling).
However, one striking effect of the Lys-to-Arg muta-
tions was noted. Following a prolonged exposure of the
cells to the a-factor ligand, rather than being delivered
to the vacuolar lumen, the Lys-to-Arg receptor was
found to localize instead to the limiting membrane of
the vacuole. Thus, while receptor ubiquitination clearly
is not required for either the a-factor-dependent up-
take into recycling pathway or for the recycling itself,
it does affect the routing of receptor to the vacuole,
likely by affecting the routing through the late endoso-
mal, multivesicular body: ubiquitinated receptor may
be selected into the internal, lumenal vesicles, while
unmodified receptor may be left to reside at the limit-
ing external membrane.
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In the yeast Saccharomyces cerevisiae, ubiquitin plays a cen-
tral role in endocytosis. The yeast plasma membrane proteins
studied to date utilize a ubiquitin-dependent endocytic mech-
anism. Mutational disruption of the cellular ubiquitination pro-
cess blocks the cell surface internalization step and also, the
subsequent degradation of internalized proteins by the yeast
vacuole/lysosome (1–3). For the two yeast pheromone re-
ceptors, i.e. the a- and the a-factor receptors, where the role
of ubiquitination in endocytosis has been well studied,
attachment of a single ubiquitin moiety to the cytosolic do-
main of the surface-localized receptor suffices as the signal
for triggering uptake (4–6). For other yeast plasma mem-
brane proteins, short multiubiquitin chains linked through
ubiquitin residue Lys-63 may be required (7,8). While promi-
nent in yeast, a role for ubiquitin in endocytosis is not limited
to the yeast cell – ubiquitin also participates in the endocytic
trafficking of a variety of mammalian plasma membrane pro-
teins (1).
The yeast a- and a-factor pheromone receptors (Ste3p and
Ste2p, respectively) are classic G protein-coupled receptors
that enable the intracellular communication which precedes
the mating of haploid a and a cell types to the a/a diploid cell.
Both receptors have been exploited as model systems in the
study of endocytosis in yeast. For Ste3p, two distinct endocytic
mechanisms which rely on different receptor signals and, to
some extent, on different trans-acting factors are employed –
a constitutive (ligand-independent) uptake mechanism and a
ligand-dependent uptake mode. Ste3p constitutive endo-
cytosis is an example of typical ubiquitin-dependent endo-
cytosis (9). The signal directing this ligand-independent up-
take is an extended, 58-residue-long PEST-like ubiquitination
signal which maps to the C-terminal end of the Ste3p regula-
tory, cytoplasmically disposed, C-terminal domain (CTD) (Fig-
ure 1) (10). This sequence is rich in both the acidic residues
aspartate and glutamate and in the hydroxylated residues ser-
ine and threonine and has three lysine residues which function
redundantly as the acceptor sites for ubiquitin attachment (5).
Ste3p ubiquitination requires the prior action of the redundant
type I casein kinases, Yck1p and Yck2p, which apparently acti-
vate the PEST-like sequence for ubiquitination through Ser/Thr
phosphorylation. Also required is the ankyrin-repeat protein
Akr1p, which functions to properly localize Yck1p/Yck2p to the
plasma membrane (11). Like other examples of ubiquitin-de-
pendent uptake in yeast, Ste3p ubiquitination involves the re-
dundant E2 ubiquitin-conjugating activities Ubc4p, Ubc5p (9),
and likely Ubc1p (12), acting together with the hect domain-
containing E3 activity Rsp5p [Y. Feng and N. Davis, unpub-
lished results (3)]. While it is clear that the attached ubiquitin
serves as the sufficient trigger for Ste3p internalization (5), the
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Figure1: Ste3p schematic indicating the position of the se-
quences that drive both constitutive (PEST-like signal) and
ligand-dependent endocytosis (NPFSTD) as well as the posi-
tions of all lysines (gray dots). The amino acid residue numbers
of these key sequences are indicated. The bracketed region below
indicates the sequences deleted by the D365 mutation.
details of how uptake is effected remain uncertain, though it is
clear that the actin cytoskeleton has some critical and central
participation (13).
As with other examples of ubiquitin-dependent uptake in
yeast, the consequence of the Ste3p constitutive endocytosis
is delivery of the receptor to the vacuole/lysosome for degra-
dation by the resident proteases (14). As a result, in resting
cells unchallenged by ligand, the mating pheromone a-factor,
Ste3p is a short-lived protein, with a half-life of only 20min
in cells growing at 30 æC (14). This correlation, for Ste3p and
for other yeast surface proteins, of ubiquitin-dependent up-
take with vacuolar degradation, suggests the possibility that
in addition to triggering uptake, the ubiquitin signal might
also be utilized at post-surface steps to direct traffic to the
vacuole.
The second Ste3p uptake mode, the ligand-dependent
mechanism, was revealed by Ste3p mutants disabled for
rapid constitutive endocytosis. Mutant Ste3 proteins that lack
either the three lysyl ubiquitin acceptor sites, or the PEST-like
signal altogether, accumulate at the surface of unstimulated
cells, but are induced to undergo endocytosis when the cells
are presented with the receptor ligand, the farnesylated pep-
tide a-factor (5,14). This uptake utilizes a different receptor
signal which includes the CTD hexapeptide sequence
NPFSTD as a required feature (Figure 1) (15). NPF tripeptide
sequences are known binding ligands for proteins with EH
(Eps15 homology) domains (16,17); of the five yeast EH do-
main proteins, three, namely End3p, Pan1p, and Ede1p,
show participation in endocytosis (18–20). In addition to rely-
ing on different receptor signals, the Ste3p ligand-dependent
uptake mechanism also relies to some extent on different
trans-acting endocytic components. Ste3p ligand-dependent
uptake does not require the Yck1p/Yck2p casein kinases or
Akr1p (11,21). Nonetheless, like all other uptake mechanisms
described to date in yeast, the actin cytoskeleton appears to
be required for Ste3p ligand-dependent uptake, as uptake is
blocked in both end4–1 and end3D cells (11,22), mutants
which disable endocytosis apparently through disruption of
the actin cytoskeleton (23–25).
Unlike the degradative outcome associated with constitutive
uptake, we have recently found that the main fate associated
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with receptor internalized into the Ste3p ligand-dependent
pathway is recycling: the bulk of receptor internalized by this
mechanism is returned to the plasma membrane, while a
more minor component is routed onward to the vacuole/lyso-
some for degradation (22). While initial examples of yeast
endocytosis were found to couple to vacuolar transport and
degradation, there has been a recent appreciation of a promi-
nent role for recycling pathways which provide a trafficking
connection of endosomal compartments back to the plasma
membrane (22,26–28). Indeed, a recent analysis of bulk en-
docytic membrane flow in yeast indicates that a major frac-
tion of membrane internalized from the cell surface rapidly
recycles back to the surface, with the onward endocytic flow
to the vacuole constituting a more minor component (28).
Given the central role played by ubiquitin in the degradative
endocytosis associated with Ste3p constitutive uptake and
the internalization of other yeast plasma membrane proteins,
we were interested to examine the role of ubiquitin in the
Ste3p recycling endocytic mode. Our previous work had
shown that Ste3p ligand-dependent endocytosis is at least
temporally associated with a ligand-dependent ubiquitination
of the receptor (9). Is this ubiquitination used for triggering
uptake or does it instead play some novel role in the Ste3p
recycling mechanism?
Results
We have made use of doa4D mutants to investigate the role
of receptor ubiquitination in the two Ste3p uptake modes.
Doa4p is one of the 17 yeast deubiquitinating enzymes (29).
By disassembling multiubiquitin chains to constituent mono-
mers, these enzymes promote ubiquitin reutilization. In doa4
mutants, free ubiquitin levels are reduced (deficient ubiquitin
reutilization) and, as a consequence, ubiquitin-dependent
processes, i.e. proteosome-mediated proteolysis and ubiquit-
in-dependent endocytosis, are impaired (4,7,8,30–32).
Effects of doa4D on Ste3p constitutive endocytosis
We have first examined the effect of doa4D on the ubiquitin-
dependent constitutive endocytosis of Ste3p. Our previous
work demonstrated that rapid constitutive ubiquitination, up-
take, and turnover of Ste3p depend both upon the cyto-
plasmic pool of free ubiquitin and upon the two functionally
redundant ubiquitin conjugating enzymes, Ubc4p and Ubc5p
(9). Thus, it is not surprising to find that Ste3p constitutive
ubiquitination and turnover are both substantially impaired in
doa4D cells (Figure 2A,B). Indeed, the doa4D blockade of
Ste3p rapid turnover has been reported previously (32). Con-
sistent with impaired turnover being a consequence of the
reduced pool of available ubiquitin, the doa4D turnover de-
fect is reversed through a compensatory over-expression of
ubiquitin from the CUP1 promoter (Figure 2C). To identify
the endocytic transport step at which the doa4D turnover
blockade is instigated, we have assessed receptor localization
in doa4D cells using our standard whole-cell protease-shav-
ing protocol (5,9,10,14,22), in which intact cells are ‘shaved’
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Figure2: DOA4 is required for the constitutive internalization of Ste3p. Ste3p expression was induced with galactose addition (2%)
to GAL1-STE3 cells that were either doa4D (NDY1241), pep4D (NDY356), or wild-type (NDY341). Following addition of glucose (3%) to
repress further GAL1-driven Ste3p synthesis, culture aliquots were removed and treated as described below. In each case, Ste3p was
visualized by Western blotting with Ste3p-specific antibodies. (A) Impaired Ste3p ubiquitination in doa4D cells. Culture aliquots were har-
vested immediately following 3h of galactose-induced Ste3p expression. Protein extracts were prepared and were treated with phosphatase
(see Materials and Methods) to eliminate the electrophoretic heterogeneity that results from heterogeneous phosphorylation. In order to
normalize Ste3p amounts, phosphatased extracts from the pep4D cells were diluted 2.5-fold relative to the other two samples prior to gel
electrophoresis. (B) Impaired Ste3p turnover in doa4D cells. At the zero timepoint, glucose was added to the three cultures, terminating a
2-h period of galactose-induced Ste3p expression. At the times indicated, culture aliquots were removed and the amount of Ste3p remaining
was determined by Western blotting. (C) Overproduction of ubiquitin suppresses the Ste3p turnover defect of doa4D cells. GAL1-STE3 cells
or GAL1-STE3 doa4D cells, transformed by either the CUP1-ubiquitin plasmid pND186 (10) or the empty vector control plasmid YEp24(2m/
URA3), were cultured as described for panel C except that 1h prior to the addition of glucose to the cultures, CuSO4 was added to 100mM,
inducing high-level ubiquitin expression. (D) Ste3p endocytosis in doa4D cells is blocked at the initial cell surface internalization step.
Following a 2-h period of galactose-induced expression and a subsequent 1.5-h period of glucose ‘chase’, culture aliquots were removed
and Ste3p localization was assessed via protease shaving of the intact cells (see Materials and Methods). The electrophoretic position of a
membrane-protected Ste3p fragment corresponding to the CTD and the seventh transmembrane domain is indicated at right by the brackets.
with proteases, added extracellularly. Receptor that localizes
to the cell surface at the time of protease addition is digested,
while receptor that localizes intracellularly is protected. For
this experiment, a 2-h ‘pulse’ of Ste3p synthesis induced
from the GAL1 promoter was followed by an additional 1.5h
‘chase’ period in which synthesis is shut off with addition of
glucose to the cultures. Cells were then removed from culture
and subjected to the protease shaving protocol. In pep4D
cells, internalized receptor accumulates intracellularly in the
vacuole (14). Consistent with such an intracellular location,
receptor is found to be wholly protected from the extracellu-
lar proteases following the 1.5h chase period (Figure 2D). A
different result is seen for the receptor which accumulates in
the doa4 cell; in this context, receptor remains largely sus-
ceptible to the protease shaving, indicated both by the loss
of the full-length receptor protein, and by the appearance of
a characteristic digestion product corresponding to the pro-
tected, cytosolic C-terminal domain (CTD; Figure 2D). We
conclude that in doa4 cells Ste3p mainly accumulates at the
cell surface, indicating that the doa4 blockade to constitutive
endocytosis is exerted at the cell surface uptake step. Thus,
the doa4 reduction to the free ubiquitin pool leads to reduced
Ste3p ubiquitination and hence, reduced uptake.
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Effects of doa4D on Ste3p ligand-dependent
endocytosis
We have applied this same panel of experiments to the
mechanistically distinct, ligand-dependent endocytic mode
(Figure 3). To follow ligand-dependent endocytosis, we have
made use of the Ste3D365 truncation mutant, which re-
moves the C-terminal 105 residues of the CTD including the
PEST-like signal for constitutive endocytosis (Figure 1) (10).
Though fully defective for constitutive endocytosis,
Ste3D365p remains competent for the ligand-dependent re-
cycling mode of endocytosis (14,22): in the absence of a-
factor ligand, Ste3D365p stably accumulates at the plasma
membrane; with a-factor addition, uptake is induced. While
recycling is the dominant outcome for receptor internalized
into this pathway, a minority of the internalized receptor
population is routed from endosomes onward to the vacuole
(22). Thus, a slow PEP4-dependent turnover of the receptor
also is associated with prolonged a-factor exposure.
First, we have examined the effect of the doa4D mutation on
the ligand-induced ubiquitination of the receptor. We have
previously found that there is clear ubiquitination of
Ste3D365p associated (at least temporally) with its ligand-
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Figure3: Effects of the doa4D mutation on the ligand-dependent endocytosis of Ste3D365p. A 2-h period of Ste3D365p expression
from GAL1-STE3D365 cells that were also either doa4D (NDY1219), pep4D (NDY358), or wild-type (NDY349) was induced with galactose
addition (2%) to the growing cultures and was terminated by the addition of glucose (3%). Following 30min of glucose chase, a-factor (see
Materials and Methods) was added to induce endocytosis. At the indicated times, culture aliquots were removed and were treated as
described below. Ste3D365p was visualized by Western blotting with Ste3p-specific antibodies. (A) Impaired Ste3D365p ubiquitination in
doa4D cells. Following a 45-min period of a-factor treatment, culture aliquots were harvested and protein extracts were prepared and treated
with phosphatase (see Materials and Methods). To normalize Ste3D365p amounts, the wild-type sample was 2-fold diluted and the pep4D
sample was diluted 3-fold. The hash marks at the right indicate the electrophoretic positions of mono- and di-ubiquitinated Ste3D365p. (B)
Effect of doa4D on ligand-induced Ste3D365p turnover. At the indicated times following a-factor addition, culture aliquots were harvested,
protein extracts were prepared and analyzed for Ste3D365p content by Western blotting. (C) Effect of ubiquitin overproduction on the ligand-
induced turnover of Ste3D365p in wild-type and doa4D cells. Wild-type and doa4D cells transformed by either the CUP1-ubiquitin plasmid
pND186 (10) or the empty vector control plasmid YEp24(2m/URA3) were cultured as described above, except that 100 mM CuSO4 was added
to the culture 30min prior to the addition of glucose. At the indicated times following a-factor addition, culture aliquots were harvested,
protein extracts were prepared and analyzed for Ste3D365p content by Western blotting. (D) Ligand-induced internalization of Ste3D365p
is undiminished in doa4D cells. At the indicated times following a-factor addition to the cultures, culture aliquots of wild-type and doa4D
cells were harvested and subjected to the protease-shaving regimen (see Materials and Methods).
induced endocytosis (9). In the pep4D cell context, a-factor
challenge results in mono- and di-ubiquitination of
Ste3D365p (Figure 3A) (9). Again, as with Ste3p constitutive
endocytosis, only a minority of the total receptor population
(10–15%) is found to be ubiquitinated at any time. One strik-
ing difference with the constitutive ubiquitination of Ste3p, is
the requirement for the cells to be pep4D to visualize this
ubiquitination: while Ste3p constitutive ubiquitination is ap-
parent in both the PEP4pi and pep4D cell contexts (Figure
2A); the ligand-dependent ubiquitination of Ste3D365p is
seen only in pep4D cells, not in PEP4pi cells (Figure 3A). This
implies that for the ligand-dependent mechanism, ubiquitin-
ated receptor is rapidly lost to vacuolar degradation, sug-
gesting the possibility that ubiquitin may be used primarily
at a late endocytic transport step, perhaps for endosome to
vacuole transport. Consistent with this possibility, we have
also found that end mutants which block both Ste3p endo-
cytic pathways at the initial surface uptake step, have quite
different effects on constitutive vs. ligand-dependent ubiquit-
ination: while constitutive ubiquitination proceeds for Ste3p
trapped at the plasma membrane by end mutants (9,11), the
a-factor-induced ubiquitination of Ste3D365p is largely
blocked in end4–1 pep4D cells (L. Chen and N. Davis, un-
published), again suggesting that ubiquitin may be used pri-
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marily at some post-surface transport step of the ligand-de-
pendent pathway.
As a first test of the role of this ligand-induced ubiquitination
in the ligand-dependent endocytic mechanism, we have
examined the effect of the doa4D mutation on the slow
ligand-dependent turnover of Ste3D365p (Figure 3B).
Ste3D365p turnover, we find, is somewhat less efficient in
doa4D cells than in wild-type cells. Nonetheless, when com-
pared to the turnover-blocked pep4D cells, it is clear that
substantial receptor turnover still does occur in the doa4D
cells (Figure 3B). To test if this partial turnover defect is a
reflection of the reduced ubiquitin pool in doa4D cells, again
we have examined the consequence of ubiquitin overpro-
duction. Somewhat surprisingly, we found that the partial
doa4D defect was not fully reversed by ubiquitin overpro-
duction: Ste3D365p turnover remains slower in doa4D cells
than in wild-type cells (Figure 3C). Finally, we have examined
the effects of the doa4D mutation on the kinetics of the
ligand-induced internalization of Ste3D365p (Figure 3D). For
this experiment, a pulse of Ste3D365p synthesis was in-
duced from the GAL1 promoter – first, transcriptional induc-
tion with galactose addition and then repression by sub-
sequent glucose addition. a-factor was then added to induce
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endocytosis and at various times thereafter, aliquots were re-
moved from both the wild-type and doa4D cell cultures, and
cells were subjected to the protease shaving protocol in order
to access surface residency of the receptor. Prior to the a-
factor challenge, all of the receptor protein in both the wild-
type and the doa4D cells is found to reside at the cell surface,
indicated by the full susceptibility to the added, extracellular
proteases (Figure 3D). At increasing times following a-factor
addition, an increasing proportion of the receptor population
becomes resistant to digestion by the extracellular proteases,
consistent with the relocalization of the receptor to the cell
interior (Figure 3D). Significantly, the kinetics of this uptake
in doa4D and in wild-type cells appears to be roughly equiva-
lent (Figure 3D). Thus, while some partial effect of the doa4D
mutation is apparent on Ste3D365p turnover (Figure 3B), the
uptake step of endocytosis appears to be unaffected by the
doa4D mutation. In this regard, the ligand-dependent uptake
mechanism differs quite strikingly from the constitutive
mechanism where Ste3p uptake was fully blocked by the
doa4D mutation (Figure 2D). The implication is that uptake
into the Ste3p ligand-dependent pathway may be ubiquitin-
independent.
Mutation of receptor ubiquitination sites
The effect of the doa4D mutation on the cellular ubiquitin
pool is a partial one; levels of free ubiquitin are reduced, not
eliminated (8,31). Therefore, the possibility remained that the
undiminished Ste3D365p internalization seen for doa4 cells
(Figure 3D) could reflect an efficient utilization of the low
levels of ubiquitin that remain in these cells. To address this
possibility and also to further investigate the potential involve-
ment of ubiquitination in receptor turnover (suggested by the
partial turnover defect of doa4D cells) (Figure 3B), we have
constructed mutant D365 receptor proteins that eliminate po-
tential ubiquitin acceptor sites from the receptor protein.
Ubiquitin is attached to substrate through a pseudo-peptide
linkage of the C-terminal ubiquitin carboxylic acid to the e-
amino group of substrate lysine residues.
Ste3D365(8K»R)p has the eight lysines of the residual 77-
residue-long D365 CTD mutated to arginine (Figure 1). Like
STE3D365, the STE3D365(8K»R) allele fully restores wild-
type mating function to a ste3D MATa cell (data not shown).
We first tested Ste3D365(8K»R)p for a-factor-induced
ubiquitination (Figure 4A). For the unsubstituted Ste3D365p,
a low constitutive ubiquitination is apparent on receptor iso-
lated from cells untreated with a-factor: both mono- and di-
ubiquitinated receptor species are apparent (Figure 4A).
Pheromone treatment results in a clear increase in the frac-
tion of receptors that are ubiquitin-modified, most of the in-
crease being mono-ubiquitinated receptor (Figure 4A). In
contrast, for Ste3D365(8K»R)p, no ubiquitinated receptor is
apparent either prior or subsequent to a-factor treatment.
Thus, the eight Lys-to-Arg substitutions abolish ubiquitin-
ation, presumably through elimination of ubiquitin acceptor
sites.
Next, we used the 8K»R receptor to address the role of
receptor ubiquitination in its ligand-induced trafficking. Does
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the ligand-dependent ubiquitination of Ste3D365p function
in uptake, in vacuole delivery, or in the recycling of receptor
back to the plasma membrane? Effects on ligand-dependent
uptake and on the slow turnover associated with this path-
way were gauged as per the experiments of Figure 3, com-
paring the kinetics of Ste3D365(8K»R)p uptake and turn-
over to those of Ste3D365p (Figure 4B,C). No effect of the
8K»R mutations can be discerned on either process. To
analyze the effects of the 8K»R mutations on recycling, we
have utilized a protocol developed in our prior work: inter-
nalization of the D365 receptor is induced by a-factor, and
then following removal of the a-factor ligand from the culture
medium, the recycling return of receptor to the plasma mem-
brane is followed using our standard protease-shaving proto-
col (22). For both Ste3D365p and Ste3D365(8K»R)p, ap-
proximately 50% of the receptor protein was found to be
internalized, following a 45-min treatment with a-factor (Fig-
ure 3D). Our previous work indicated that when the presence
of the ligand is maintained in the culture medium, the recep-
tor population reaches a trafficking equilibrium in which con-
tinued internalization of the receptor is balanced by its recyc-
ling return to the plasma membrane (22). When ligand is
withdrawn from the system, continued internalization termin-
ates, and the recycling return to the plasma membrane of the
internalized portion of the receptor population can be directly
visualized (22). Comparing Ste3D365(8K»R)p and
Ste3D365p in this recycling protocol, we can discern no dif-
ference in terms of the kinetics of the return of the internal-
ized receptor back to the cell surface: i.e. following the re-
moval of a-factor from the cultures, the two receptors regain
susceptibility to the extracellular proteases with roughly
equivalent kinetics (Figure 4D).
Thus, all three aspects of receptor trafficking within the
ligand-dependent endocytic pathway, i.e. uptake, recycling
and slow vacuolar turnover, appear to be unaffected by the
8K»R mutations. To eliminate the possibility that some
transient ubiquitination of the receptor may still be occur-
ring, we have constructed another receptor mutant
Ste3D365(15K»R)p, which in addition to the 8K»R muta-
tions, also has Lys-to-Arg substitutions of the seven lysine
residues that map to the cytoplasmically disposed loops of
the receptor (Figure 1). We were somewhat concerned that
these additional mutations which map into the receptor
core domain might disrupt receptor function: e.g. ligand-
binding, G-protein-coupling, proper folding or transport to
the cell surface via the secretory pathway. In qualitative
tests of mating efficiency the STE3D365(15K»R) allele was
found to fully complement ste3D (data not shown), indi-
cating that the function is largely preserved for the mutant
receptor. Nonetheless, assessments of the rate at which the
newly synthesized receptor is delivered to the cell surface
(utilizing the protease-shaving protocol) indicated that
Ste3D365(15K»R)p traversed the secretory pathway
somewhat more slowly than did Ste3D365p (data not
shown). To compensate for this, experiments involving
Ste3D365(15K»R)p had the glucose chase period ex-
tended; following a 2-h galactose-induced expression
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Figure4: No effect of the 8K»R mutations on uptake, recycling, or turnover within the Ste3p ligand-dependent endocytic
pathway. The ligand-dependent ubiquitination and endocytosis of Ste3D365p and Ste3D365(8K»R)p are compared. For each of the
experiments below, cells were cultured for GAL1-driven receptor expression as described for Figure 2 and receptor protein was visualized
by Western blotting with Ste3p-specific antibodies. (A) Effect of the 8K»R mutations on a-factor-induced receptor ubiquitination. At the
indicated times following a-factor addition, culture aliquots of GAL1-STE3D365 pep4D cells (NDY358) or of GAL1-STE3D365(8K»R) pep4D
cells (NDY1310) were harvested, protein extracts were prepared and then treated with phosphatase (see Materials and Methods) prior to
gel electrophoresis. The previously determined electrophoretic positions of mono- and di-ubiquitinated Ste3D365p (9) are indicated by the
arrows to the left. The hash mark at left indicates the position of a protein that cross-reacts with the Ste3p antibodies: this band is also
present in extracts from the ste3D control cells which were processed in parallel for this experiment. (B) The ubiquitination-deficient 8K»R
receptor shows unimpaired ligand-dependent uptake. At the indicated times following a-factor addition, GAL1-STE3D365 (NDY349) or
GAL1-STE3D365(8K»R) (NDY1309) cells were harvested and subjected to the protease-shaving regimen (see Materials and Methods).
(C) The ubiquitination-deficient 8K»R receptor shows undiminished turnover. Receptor content was assessed by Western blotting of
extracts prepared from culture aliquots of GAL1-STE3D365 (NDY349) or GAL1-STE3D365(8K»R) (NDY1309) cells, harvested at the times
indicated following treatment with a-factor or following mock pheromone treatment (no a-F). (D) Recycling is unimpaired for the ubiquitin-
ation-deficient 8K»R receptor. Following a 45-min treatment of GAL1-STE3D365 (NDY349) or GAL1-STE3D365(8K»R) (NDY1309) cells
with a-factor (pia-F), a-factor was withdrawn from the cell cultures (see Materials and Methods) and the return of internalized receptor to
the cell surface was followed by protease shaving (see Materials and Methods).
period (terminated by glucose addition), the time period
preceding a-factor addition was extended from the usual
30min to 1h, allowing for a greater proportion of the newly
synthesized Ste3D365(15K»R)p to reach the cell surface.
First, we examined the capacity of Ste3D365(15K»R)p for
ligand-induced uptake (Figure 5A). Like the 8K»R receptor,
the 15K»R receptor was internalized with kinetics indis-
tinguishable from the unsubstituted Ste3D365p (Figure 5A).
As Ste3D365(15K»R)p lacks any ubiquitin acceptor sites,
we conclude that uptake via the Ste3p ligand-dependent en-
docytic mechanism does not depend on cis-ubiquitination of
the receptor protein. To address whether the ligand-induced
ubiquitination might instead be devoted to the downstream
endocytic trafficking to the vacuole, we examined the effect
of the 15K»R mutations on a-factor-induced receptor turn-
over. Again here, as with the 8K»R receptor, we are unable
to observe any clear effect on the rate at which
Ste3D365(15K»R)p is degraded relative to Ste3D365p (Fig-
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ure 5B). Thus, we conclude that ubiquitination does not in-
fluence the rate at which the D365 receptor is delivered to
the vacuole. This conclusion is somewhat at odds with the
partial turnover defect observed for Ste3D365p in doa4D
cells (Figure 3B). The finding that this doa4 turnover defect
is not suppressed by ubiquitin overproduction (Figure 3C),
indicates that it is not due to a doa4-mediated depletion of
the ubiquitin pool. Instead, the partial turnover defect could
indicate some direct action of Doa4p on the vacuolar trans-
port of Ste3D365p. In this regard, a recent report indicates
that Doa4p acts directly upon ubiquitinated endocytic sub-
strates, as they traverse the late endocytic pathway (33).
A C-terminal fragment is proteolytically released from
the 8K»R receptor in vivo
In terms of uptake, recycling, and turnover, elimination of
ligand-induced ubiquitination of Ste3D365p is without dis-
cernible consequence. One curious difference between
Ste3D365(8K»R)p and Ste3D365p was noted, however. In
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Figure5: The 15K»R Lys-to-Arg receptor substitution muta-
tions do not affect the kinetics of ligand-induced internaliz-
ation or turnover. GAL1-STE3D365 (NDY349) or GAL1-
STE3D365(15K»R) (NDY1478) cells were cultured as described
for Figure 2, except that the glucose chase period prior to a-factor
treatment was increased from 30min to 1h to allow a greater frac-
tion of the 15K»R mutant receptor population to reach the plasma
membrane. Receptor is visualized for these experiments by Western
blotting with Ste3p-specific antibodies. (A) Receptor ubiquitination
is not required for the uptake step of ligand-dependent endocytosis.
At the indicated times following a-factor addition, culture aliquots
were harvested and subjected to the protease-shaving protocol,
then gel electrophoresis and Western blotting. (B) Ubiquitination of
the receptor is not required for its slow ligand-dependent turnover.
At the indicated times following the addition of a-factor, culture ali-
quots were harvested and protein extracts were prepared for West-
ern blotting.
the protease-shaving protocol, a diagnostic feature of suc-
cessful extracellular proteolysis of surface-localized receptor
is the generation of a membrane-protected Ste3 CTD frag-
ment resulting from proteolytic clipping within the exposed,
third extracellular loop. Indeed, in the absence of a-factor,
where both Ste3D365p and Ste3D365(8K»R)p are local-
ized fully to the plasma membrane, protease shaving results
in near complete conversion of surface-localized receptor to
Figure6: A proteolytic fragment associated with
Ste3D365(8K»R)p endocytosis. Cells were cultured for GAL1-
driven receptor expression and then ‘chased’ with glucose for an
additional 30min as described for Figure 2. Receptor proteins were
visualized by Western blotting with Ste3p-specific antibodies. The
position of Ste3-derived protein fragments are indicated to the right
of each panel (CTD). (A) a-factor treatment results in the production
of a receptor fragment from Ste3D365(8K»R)p that comigrates
with the CTD fragment produced by protease shaving of surface-
localized receptor. Localizations of Ste3D365p and of
Ste3D365(8K»R)p in NDY349 and NDY1309 cells, respectively,
were assessed by protease-shaving immediately prior to, or follow-
ing a 45-min treatment with a-factor. (B) The a-factor-dependent
8K»R CTD fragment is C-terminal. Cells expressing either
Ste3D365(8K»R)p (NDY1309) or Ste3D365(8K»R)-(myc)p
(NDY1450), which has an additional 18-residue sequence, includ-
ing the myc epitope, appended to the C-terminal end of the trunc-
ated D365 receptor, were treated with a-factor or proteases as de-
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the CTD fragment (Figure 6A). [Other receptor fragments de-
rived from this shaving, e.g. N-terminal receptor fragments,
are not visualized because the Ste3-specific antibodies used
for this detection were raised exclusively against a Ste3 CTD
scribed for panel A. The added epitope tag results in reduced elec-
trophoretic mobility both for undigested receptor and for the C-
terminal proteolytic fragment (CTD-myc). (C) The a-factor-induced
generation of the Ste3D365(8K»R)p-derived CTD fragment
depends on endocytosis and on vacuolar proteolytic activity. GAL1-
STE3D365 (NDY349), GAL1-STE3D365(8K»R) (NDY1309),
GAL1-STE3D365(8K»R) pep4D (NDY1310), and GAL1-
STE3D365(8K»R) end3D (NDY1482) cells were cultured, chal-
lenged with a-factor (pi) or not (–), and then cells were collected
and processed as for the no protease control samples of panel A
(i.e. no extracellular proteases added).
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antigen (14)]. With 45min of a-factor treatment, the receptor
populations are, as expected, found to be divided between
surface and intracellular locales; the intracellular subpopula-
tion resists digestion, while the portion which remains at the
surface is proteolyzed, giving rise to CTD digestion product.
Curiously, in the no-protease control sample of the a-factor-
treated Ste3D365(8K»R)p-expressing cells but not in the
parallel sample from the Ste3D365p cells, a Ste3 fragment is
seen which corresponds roughly in size to the CTD digestion
product generated by protease shaving (Figure 6A). To ascer-
tain the identity of this a-factor-induced fragment, we have
modified the Ste3D365(8K»R)p gene to encode a receptor
with an additional 18 residues including the myc epitope tag
fused at the C-terminus. The added peptide sequences retard
the gel electrophoresis both of the full-length receptor protein
and of the C-terminal shaving product (Figure 6B). The a-
factor-induced fragment from these Ste3D365(8K»R)-
(myc)p-expressing cells shows the same retarded gel mo-
bility as the fragment produced by protease shaving (Figure
6B). This indicates that, like the shaving product, this frag-
ment also is C-terminal. Extrapolating further, the fact that
both the fragment generated by shaving and the fragment
induced by a-factor treatment are C-terminal and are of simi-
lar molecular weight indicates that both also share similar N-
terminal endpoints, likely generated in both cases by clipping
within the same third extracellular loop domain. For the pro-
tease-shaving experiment, proteolysis of the surface-local-
ized receptor within the extracellular oriented loop domains
is expected. In the absence of added proteases, how might
a-factor stimulate clipping within this same loop?
To test if the a-factor-induced clipping might be a conse-
quence of the a-factor-induced endocytosis of the 8K»R
receptor, we have examined the effect of the end3D mutation
on this fragment production; END3 function is required for
uptake into both of the Ste3p constitutive and ligand-de-
pendent endocytic pathways (11). The end3D mutation, we
find, blocks CTD fragment production (Figure 6C), indicating
that the a-factor-induced proteolysis depends upon receptor
internalization into the cell, suggesting further that the re-
sponsible protease may reside intracellularly. A clue regard-
ing the identity of the responsible protease activity comes
from the additional finding that CTD fragment production is
blocked in pep4D cells (Figure 6C); thus, fragment produc-
tion requires vacuolar protease activity. One model that could
accommodate both the need for endocytosis and vacuolar
proteolytic activity would have the internalized 8K»R recep-
tor delivered to the limiting membrane of the vacuole; recep-
tor orientation would be expected to be such that its ‘extra-
cellular’ loops would protrude into the vacuolar lumen and
would thus be available for digestion by resident proteases,
while ‘cytoplasmic’ loops would remain within the cytoplasm
and thus be protected.
Ubiquitination controls vacuolar localization
For several plasma membrane polytopic integral membrane
proteins, endocytosis has been shown to deliver the internal-
ized proteins to the interior space of the vacuole, rather than
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to the limiting vacuolar membrane as might be expected for
transport via typical vesicular trafficking mechanisms (33–
37). Such proteins are thought to reach the lumens of the
yeast vacuole or mammalian lysosome on small vesicles, re-
leased into the interior space through fusion of the late endo-
some, the multivesicular body (MVB), with the vacuole/lyso-
some (34,38). The preceding step, i.e. how vesicles first get
internalized into the MVB lumenal space, is not yet under-
stood.
In Figure 7, we have examined the localization in pep4D cells
of HA-epitope-tagged receptors by indirect immunofluore-
scent microscopy following an extended 2-h treatment of
cells with a-factor. Although recycling is the major fate for
internalized D365 receptor, with long exposure to a-factor,
eventually (presumably after multiple rounds of uptake and
recycling), the bulk of the receptor is delivered to the vacuole
where in PEP4pi cells it is degraded and in pep4D cells, it is
sequestered (14,22). This analysis was facilitated by a change
in the yeast strain background. The strain background used
for the prior experiments [derived from HR144–3D (18)] has
small vacuoles (data not shown), making it difficult to distin-
guish if receptor is delivered to the vacuole interior or not.
The strain background that we have instead used (derived
from LRB757) (39) has relatively large vacuoles (Figure 7).
While the two strains differ in terms of the physical presen-
tation of the vacuoles, vacuolar function, assessed in terms
of the kinetics of Ste3p turnover, is indistinguishable (data
not shown). Most relevant with regard to the immunofluor-
escence analysis presented below (Figure 7), as was seen
previously in the HR144–3D strain background (Figure 4C),
Ste3D365(8K»R)p cannot be distinguished from
Ste3D365p in terms of the kinetics of its ligand-induced turn-
over, indicating that there is no difference in the rate at which
the two receptors are delivered to the vacuole.
First we have examined the endpoint localization of HA-tagged
wild-type Ste3p internalized via the constitutive endocytic
pathway. Localization was assessed in pep4D cells, 2.5h sub-
sequent to glucose-mediated repression of Ste3(HA)p syn-
thesis from the GAL1 promoter. Receptor staining at this time-
point was found to be wholly intracellular, the surface having
been fully cleared by endocytosis (Figure 7). Receptor was
visualized as discrete puncta mapping into the lumenal space
of the vacuole (by Nomarski optics, the vacuole presents as an
apparent depression of the cell surface; note ‘composite’ im-
age having the red fluorescent signal superimposed onto the
Nomarski image; Figure 7). This presentation is consistent with
localization to intravacuolar vesicles. The images displayed are
deconvolved cross-sections (see Materials and Methods); in-
spection of neighboring sections identifies additional intravac-
uolar puncta (not shown); on average, 5–10 puncta can be dis-
tinguished per vacuole. Thus, we conclude that Ste3p consti-
tutive endocytosis delivers receptor-containing vesicles to the
vacuole lumen.
For receptor internalized via the ligand-dependent pathway,
we find that Ste3D365p following the 2h a-factor treatment
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Figure7: The 8K»R receptor is delivered to the limiting membrane of the vacuole rather than to vacuole interior. A 3-h period
of galactose-induced expression of HA epitope-tagged Ste3p, Ste3D365p, and Ste3D365(8K»R)p in the pep4D strains NDY1475,
NDY1457, and NDY1458, respectively, was followed by a 2.5h glucose chase period. Ste3D365p- and the Ste3D365(8K»R)p-expressing
cells had a-factor added for the final 2h of the glucose chase period to induce endocytosis. Cells were prepared for immunofluorescent
analysis (see Materials and Methods) and incubated with anti-HA mAb, followed by a Cy3-conjugated goat anti-mouse antibody. The panels
at left are the result of computer deconvolution of the fluorescent signal at a single focal plane. The same focal plane of the same cells is
imaged in the middle panels by DIC. Panels at right show a superposition of the fluorescent signal (red) overlaid onto the DIC image. A 10-
mm scale bar (white) is seen in the bottom right panel.
shows an endpoint localization quite similar to that seen for
wild-type receptor internalized via the constitutive pathway.
Following such an extended a-factor treatment, receptor is
again found to be exclusively intracellular, again localizing to
intravacuolar puncta (Figure 7). Quite a different result
was seen with the parallel analysis of internalized
Ste3D365(8K»R)p. Rather than intravacuolar puncta, the
8K»R receptor instead appears to decorate the limiting mem-
brane of the vacuole (Figure 7). Thus, while ligand-induced
ubiquitination is not utilized to direct uptake, recycling or turn-
over of the receptor, it does appear to play a role in directing
receptor traffic into the vacuole lumen.
Discussion
Ubiquitin-independent endocytosis
Previous work has shown that different receptor signals and to
some extent, different cellular proteins are used to instigate up-
take into the two Ste3p endocytic pathways (11,14,15,21). Re-
ceptor internalized into the two pathways also differs in terms
of fate – constitutive uptake leads to rapid degradation in the
vacuole, while the ligand-dependent mechanism couples
largely to recycling (14,22). In the present work, we find an-
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other major difference in terms of the role that ubiquitin plays
in the two mechanisms.
First, the doa4D mutation which reduces ubiquitin availability
within the cell was found to have quite a different effect on
the two uptake mechanisms. While the doa4D mutation
blocked the ubiquitin-dependent, constitutive uptake of the
receptor (Figure 2D), no discernible effect on the ligand-de-
pendent uptake of Ste3D365p (Figure 3D) was seen. Al-
though this could indicate that ubiquitination is not required
for ligand-dependent uptake, the possibility remained that
the undiminished uptake seen for doa4D cells might instead
result from efficient scavenging of the low residual levels of
ubiquitin that remain available in these cells. To address this
possibility, Lys-to-Arg missense mutations were introduced
into Ste3D365p to eliminate potential ubiquitination sites
within the receptor protein. The 8K»R mutant removed all
eight lysines from the residual D365 CTD (Figure 1), while the
15K»R mutant additionally removed the seven lysine resi-
dues that map to the three cytoplasmic loops of the receptor
protein (Figure 1). Neither of these two Lys-to-Arg mutant
receptors showed any impairment in terms of their ligand-
induced internalization (Figures 4B and 5A). Thus, we feel
confident in concluding that uptake into the Ste3p ligand-
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dependent pathway does not require ubiquitination of the re-
ceptor and thus stands uniquely in yeast as a ubiquitin-inde-
pendent uptake mechanism. Consistent with this conclusion,
it has been reported recently that an NPF sequence intro-
duced into the context of a mutant a-factor receptor (Ste2p),
having all the lysine residues of the Ste2p CTD substituted
by arginines, was able to restore endocytic function indi-
cating that NPF-mediated uptake in general may be ubiquitin
independent (40). However, this mutant Ste2p construct did
retain the lysine residues that map to the cytosolic loops of
the a-factor receptor; thus, some possibility of receptor
ubiquitination remained.
Recycling – the default sorting option?
The various examples of ubiquitin-dependent uptake in yeast
studied to date all lead to rapid degradation of the internal-
ized substrate protein in the vacuole (1,2), suggesting the
possibility of obligate coupling of ubiquitin-dependent uptake
to vacuole-directing trafficking and turnover. It seems sig-
nificant in this regard that the one example of ubiquitin-inde-
pendent uptake, i.e. the ligand-dependent uptake of
Ste3D365p described herein, is instead most prominently as-
sociated with recycling. Thus, while cell-surface ubiquitin-
ation may route the endocytic substrate to the vacuole for
degradation, ubiquitin-independent uptake may couple in-
stead into a recycling pathway. A recent report on bulk mem-
brane flow in yeast indicates that a major fraction of mem-
brane internalized from the cell surface rapidly recycles back
to the surface, with the onward endocytic flow to the vacuole
constituting a more minor component (28). In the absence
of a ubiquitin signal to direct the onward transport to the
vacuole, internalized receptor may simply ride the bulk flow
of membrane back to the surface. In this scenario, recycling
would be the default and recycling substrates would not re-
quire specialized signals to specify routing back to the sur-
face. In this regard, it will be interesting to see if the two
other yeast examples of recycling proteins, chitin synthetase
Chs3p (26) and Snc1p SNARE protein (27), also are internal-
ized via ubiquitin-independent mechanisms. Default recycling
in yeast is consistent with the current understanding of recyc-
ling in mammalian cells. As in yeast, mammalian cell mem-
brane recycling constitutes a major portion of the bulk endo-
cytic membrane flow (41). Furthermore, it appears that the
recycling of internalized receptors does not require a special-
ized signal, occurring instead by default (42).
Ubiquitination directs transport into the vacuole lumen
What then is the function of Ste3p ligand-induced ubiquitin-
ation? While elimination of receptor cis-ubiquitination does
not grossly perturb the rate at which receptor is turned over,
we have found that receptor ubiquitination does have a strik-
ing effect on the receptor’s final vacuolar localization. This is
clearly seen for the endpoint localizations of Ste3D365p and
Ste3D365(8K»R)p following an extended treatment of the
cells with a-factor (Figure 7). Ste3D365p, like wild-type
Ste3p delivered to the vacuole via constitutive endocytosis,
accumulates in punctate structures within the vacuolar in-
terior. In contrast, Ste3D365(8K»R)p was found to decorate
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the limiting membrane of the vacuole. This finding suggests
that attached ubiquitin may play a role in directing how sub-
strate is delivered to the vacuole, i.e. whether it is delivered
to the interior space of the vacuole, or alternatively, to the
limiting membrane. Delivery of membrane proteins to the
vacuole lumen is thought to occur through fusion of the mul-
tivesicular late endosome with the vacuole/lysosome (34,38).
The multivesicular body (MVB) is a topologically complex or-
ganelle having interior vesicles contained within a limiting
outer membrane. Fusion of the MVB with the vacuole/lyso-
some delivers the MVB lumenal vesicles into the lumen of the
vacuole/lysosome, while proteins present in the MVB limiting
membrane may transfer to the vacuole/lysosome limiting
membrane (27,43). The punctate presentations of endocytos-
ed Ste3p and Ste3D365p are consistent with localization to
lumenal vacuolar vesicles. The two different endpoint localiz-
ations for ubiquitinated and non-ubiquitinated receptors point
toward a role for the ubiquitin signal in directing traffic
through the MVB, with active sequestration of the ubiquitinat-
ed receptor into lumenal MVB vesicles.
Our results are consistent with several recent reports that in-
dicate a new, generalized role for ubiquitin in directing late
endosomal traffic through the MVB into the vacuole lumen
(37,44–46). The MVB provides a convergent trafficking step
to the vacuole/lysosome, both for endocytic traffic from the
plasma membrane and for biosynthetic traffic of the newly
synthesized hydrolases that are delivered to the vacuole from
the Golgi (14,47–49). Thus, in addition to the role of ubiquitin
in sorting at the MVB for endocytic traffic to the vacuole, as
indicated both by our work on Ste3p and by a prior report
on the ABC transporter Ste6p (37), a similar role for ubiquitin
at the MVB has now also been suggested for the biosynthetic
traffic of the newly synthesized hydrolases to the vacuole
lumen (44,46). In addition, there has also been exciting pro-
gress in the elucidation of the mechanism by which the
ubiquitinated substrate is sequestered into the MVB lumenal
vesicles – a protein complex composed of Vps23p, Vps28p,
and Vps37p, apparently acts at the MVB to recognize the
ubiquitinated substrates and somehow to direct seques-
tration into the lumenal vesicles (44).
Thus, in addition to its role in directing endocytic uptake at
the plasma membrane in yeast, it is now clear that ubiquitin
also is utilized to direct traffic late in the endocytic pathway
through the MVB. This new role for ubiquitin likely also ap-
plies to the endocytic trafficking in mammalian cells. A late-
acting function for receptor ubiquitination has also been es-
tablished for the EGF and IL-2 receptors: ubiquitinated recep-
tors are preferentially targeted for lysosomal destruction,
rather than for recycling (50,51).
The Ste3p ligand-dependent endocytic pathway
Our previous work demonstrated recycling to be the primary
fate of receptor internalized by the ligand-dependent uptake
mechanism (22). Here, we show that the ubiquitin signal is
required neither for the uptake nor for the associated recyc-
ling. From this, we extrapolate a general model in which re-
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cycling is seen as the default option, i.e. sorting that does not
require a specialized signal. Based upon published analysis
of bulk endocytic membrane flow (28), we expect that the
Ste3p recycling compartment is likely to be the early endo-
some. Although the receptor may normally be subject to
multiple rounds of ligand-induced uptake and recycling,
eventually, with prolonged exposure of the cells to a-factor,
appreciable amounts of receptor are removed from the recyc-
ling pathway and directed onward to the MVB and vacuole
for degradation; under such conditions of continuous ligand
exposure, the receptor half-life for degradation is typically
about 90min (Figures 3–5) (22). Again here, ubiquitination
is not required for this redirection out of the recycling path-
way; the kinetics of vacuole-dependent turnover are not
compromised for the non-ubiquitinatable 8K»R and
15K»R receptor mutants (Figures 3C and 4B). Indeed, it is
only at the final transport step, the transit of receptor through
the MVB to the vacuole, that we find a role for ubiquitination:
ubiquitinated receptor being sequestered into the lumenal
vesicles of the MVB and then to the vacuole lumen, while
the ubiquitination-deficient 8K»R receptor is instead de-
livered to the vacuole limiting membrane. Consistent with a
late role for ubiquitination in the ligand-dependent pathway,
we are able to detect the receptor ubiquitination only in
pep4D cells (Figure 3A) (in contrast to the ubiquitination as-
sociated with the constitutive endocytosis of the receptor:
Figure 2A). This implies that ubiquitinated receptor species
are short lived, suggesting that ubiquitination may occur just
prior to the PEP4-dependent degradation of the receptor,
perhaps added to the receptor while resident at the MVB.
Given the striking effect of ubiquitination on the vacuolar
localization of the receptor, it is surprising that we detect no
major difference in the kinetics of turnover for the ubiquitinat-
ed vs. the ubiquitination-deficient receptors. Apparently, re-
Table1: Yeast strains
Strain Genotype Reference or Sourcea
EG123 MATa ura3 leu2 trp1his4 (56)
NDY341 MATa GAL1-STE3 ura3 leu2his4 bar1–1 (9)
NDY343 MATa ste3D::LEU2 (10); A
NDY349 MATa GAL1-STE3D365 (22); A
NDY356 MATa GAL1-STE3 pep4D (9); A
NDY358 MATa GAL1-STE3D365 pep4D (22); A
NDY372 MATa ste3D::LEU2 pep4D (5); A
NDY1219 MATa GAL1-STE3D365 doa4D::G418R This work; A
NDY1241 MATa GAL1-STE3 doa4D::G418R This work; A
NDY1309 MATa GAL1-STE3D365(8K»R) This work; A
NDY1310 MATa GAL1-STE3D365(8K»R) pep4D This work; A
NDY1450 MATa GAL1-STE3D365(8K»R)-(c-myc) This work; A
NDY1478 MATa GAL1-STE3D365(15K»R) This work; A
NDY1482 MATa GAL1-STE3D365(8K»R) end3D::G418R This work; A
NDY1080 MATa GAL1-STE3 pep4D ura3–52 leu2his3 (11)
NDY1456 MATa ste3D::LEU2 pep4D This work; B
NDY1457 MATa GAL1-STE3D365-(HA) pep4D This work; B
NDY1458 MATa GAL1-STE3D365(8K»R)-(HA) pep4D This work; B
NDY1475 MATa GAL1-STE3-(HA) pep4D This work; B
a Strains designated A are isogenic to NDY341 except as indicated. Strains designated B are isogenic to NDY1080 except as indicated.
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ceptor can be efficiently turned over even when delivered to
the limiting membrane of the vacuole. Furthermore, receptor
localized to this limiting membrane is not merely clipped (as
is seen in Figure 6), but rather fully degraded; preliminary
data indicate that the PEP4-dependent CTD proteolytic clip-
ping product (Figure 6) is a relatively long-lived intermediate
in the process of more complete degradation of the receptor
protein (data not shown); clipped CTD products do not ac-
cumulate to significant extents in the typical ligand-depend-
ent turnover experiments such as those shown for
Ste3D365(8K»R)p (Figure 4C) and Ste3D365(15K»R)p
(Figure 5B).
Our work on the Ste3p ligand-dependent endocytic pathway
presents two new paradigms connecting ubiquitin and endo-
cytosis. First, we find that receptor internalized via a ubiquit-
in-independent uptake mechanism recycles. Recycling, we
hypothesize, may be the default sorting mechanism that oc-
curs in the absence of the ubiquitin signal. In addition, our
work provides support for an exciting new role for ubiquitin
in directing traffic through the MVB, with ubiquitinated sub-
strate being internalized into lumenal vesicles and with the




The strains used in this work are listed in Table1.The new strains con-
structed for this work were constructed using standard yeast gene replace-
ment methodologies. Disruption of the DOA4 and END3 genes involved
exact PCR-mediated replacement of the ORFs by the G418R-conferring
kan-MX2 allele (52), essentially as previously described (11). Other strains
were constructed through introduction of mutant STE3 alleles into the
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chromosome at the STE3 locus in place of an endogenous ste3D::LEU2
allele (10) by a two-step gene replacement methodology previously de-
scribed (9). The ste3D::LEU2 starting strains for these constructions were
NDY343 (10), NDY372 (5), and NDY1456. NDY1456 was constructed by
two-step gene replacement of the GAL1-STE3 allele of NDY1080 (11) by
the ste3D::LEU2 allele of pSL2165 integrating plasmid (10).
Lys-to-Arg STE3 mutant alleles
The new STE3 alleles for chromosomal integration all were constructed
from the starting point of the GAL1-STE3 pSL1904 integrating plasmid (5).
D365 is an in-frame deletion of sequences encoding residues 365–468
of Ste3 (14). The GAL1-STE3D365(8K»R) allele substitutes Arg codons
for the eight Lys codons of the residual D365 CTD (Figure 1): i.e. K291R,
K297R, K306R, K311R, K313R, K315R, K323R, K328R. These 8K»R Lys-
to-Arg substitutions were introduced into GAL1-STE3D365 plasmid on a
mutated 231bp STE3 Nde I to Sal I restriction fragment (encoding Ste3
residues 288 through 365) generated by the PCR-based SOEing method-
ology (53), using three 100-mer oligonucleotides that overlapped with one
another by 20bp. The seven additional Lys-to-Arg substitutions (i.e. K29R,
K99R, K102R, K105R, K185R, K186R, K188R) (Figure 1) present in the
15K»R allele were generated by separate oligonucleotide-directed muta-
genesis (54) of the Lys codons present in the sequences encoding the
three Ste3p cytoplasmic loops. The fidelity of the introduced mutations
was confirmed through DNA sequencing of the relevant portions of the
final 8K»R and 15K»R mutant plasmids.
Epitope-tagged STE3 alleles
To construct the GAL1-STE3D365(8K»R)-(c-myc) allele, the c-myc 9E10
epitope fused to the C-terminal sequences of a GAL1-STE3D365(c-myc)
construct (14) was ligated to the C-terminal sequences of a GAL1-
STE3D365(8»R) construct. With the epitope addition, 18 residues are
added to the C-terminus of Ste3D365(8K»R)p. To construct the C-ter-
minally HA epitope-tagged Ste3p, i.e. GAL1-STE3-(HA), a DNA duplex
composed of two annealed, complementary 33-mer oligonucleotides en-
coding a single HA epitope and having Xho I/Sal I complementary 5ƒ over-
hangs, was inserted at an Xho I restriction site previously created by oligo-
nucleotide-directed mutagenesis (54) at STE3 C-terminal codons 466 and
467 (5). The Xho I site re-created to the upstream side of the tag-encoding
sequence of GAL1-STE3-(HA) was used for ligation to C-terminal Sal I
sites present in both the GAL1-STE3D365 and GAL1-STE3D365(8K»R)
constructs, generating the HA epitope-tagged versions of these alleles.
Cell culture, a-factor treatment, protein extract preparation, and
Western analysis
A period of receptor expression was induced from strains carrying the vari-
ous GAL1-driven STE3 mutant alleles growing in YPR medium (1% yeast
extract, 2% peptone, 2% raffinose) with addition of galactose to 2% and
was terminated with the subsequent addition of glucose to 3%. Sub-
sequent treatment with a-factor, involved the addition of a 0.5 vol of a
culture supernatant from EG123 cells carrying the a-factor overproduction
plasmid pKK16(2m/URA3/STE6/MFA2) (14,55). Aliquots removed from cul-
tures just prior to the a-factor treatment step (the zero timepoint), or at
indicated times thereafter, were either directly processed into protein ex-
tracts or were subjected to the protease-shaving protocol. Protein extracts
were prepared for SDS-PAGE and Western analysis as previously de-
scribed (5).
Phosphatase treatment
Visualization of the ubiquitinated receptor forms is facilitated by reducing
the heterogeneity in receptor gel mobility caused by its heterogeneous
phosphorylation. For this, protein extracts were treated with potato acid
phosphatase (Roche, Nutley, NJ, USA) as described (9) prior to SDS-
PAGE.
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Protease shaving
To assess the fraction of the receptor population residing at the cell sur-
face, intact cells were treated with Pronase (Calbiochem-Novabiochem,
San Diego, CA, USA) or mock-treated in parallel (no added protease) as
previously described (14,22). Energy poisons (10mM sodium azide, 10mM
potassium fluoride) are included during the 60-min digestion as well as
during a 30-min preincubation to block the possibility of ongoing receptor
trafficking. Extracts prepared through glass bead lysis of the cells into 10%
trichloroacetic acid (14) were subjected to SDS-PAGE and then Western
analysis.
Recycling
The recycling of internalized receptor was followed as previously described
(22). In brief, following 45min of a-factor treatment (which resulted in
substantial internalization of the D365 receptor), cells were collected from
culture by centrifugation, washed with fresh medium and restored to cul-
ture. The rate of recycling return of the internalized receptor back to the
cell surface was then followed using the protease shaving protocol.
Indirect immunofluorescent microscopy
Cells were fixed, spheroplasted, and otherwise prepared for indirect im-
munofluorescent microscopy as described (14). Detection of HA-epitope-
tagged receptor proteins entailed a 1-h incubation with a 1 :1000 dilution
of the HA.11 mAb (Covance, Princeton, NJ, USA) followed by a secondary
1-h incubation with a 1 :500 dilution of a Cy3-conjugated donkey anti-
mouse IgG (Jackson ImmunoResearch, West Grove, PA, USA). A z-series
of digital images of the fluorescent cells collected at focal planes separated
by 0.25mm increments using a Nikon Eclipse 800 microscope equipped
with epifluorescence, an ORCA II CCD camera (Hamamatsu, Bridgewater,
NJ, USA), and motorized stage. Fluorescent images were deconvolved
using Inovision ISee software (Inovision, Raleigh, NC, USA).
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